|
Volumn 11, Issue 5, 2001, Pages 663-667
|
Addressing the stability of C-capped dipeptide efflux pump inhibitors that potentiate the activity of levofloxacin in Pseudomonas aeruginosa
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DIPEPTIDE;
LEVO OR;
LEVOFLOXACIN;
MC 02595;
MEXAB OPRM EFFLUX PUMP;
ORNITHYLPHENYLALANINE 3 AMINOQUINOLINE;
PHENYLALANYLARGININE 2 NAPHTHYLAMIDE;
PHENYLALANYLARGININE BETA NAPHTHYLAMINE;
PROTEIN;
UNCLASSIFIED DRUG;
ARTICLE;
DRUG POTENTIATION;
DRUG STABILITY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
DRUG TRANSPORT;
GRAM NEGATIVE INFECTION;
MINIMUM INHIBITORY CONCENTRATION;
NONHUMAN;
PROTEIN EXPRESSION;
PSEUDOMONAS AERUGINOSA;
RAT;
STRUCTURE ACTIVITY RELATION;
ANIMALS;
ANTI-INFECTIVE AGENTS;
BIOLOGICAL TRANSPORT, ACTIVE;
DIPEPTIDES;
DRUG DESIGN;
DRUG STABILITY;
DRUG SYNERGISM;
MICE;
MICROBIAL SENSITIVITY TESTS;
MOLECULAR CONFORMATION;
MOLECULAR STRUCTURE;
OFLOXACIN;
PSEUDOMONAS AERUGINOSA;
RATS;
STRUCTURE-ACTIVITY RELATIONSHIP;
PSEUDOMONAS;
PSEUDOMONAS AERUGINOSA;
|
EID: 0035848421
PISSN: 0960894X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0960-894X(01)00033-6 Document Type: Article |
Times cited : (57)
|
References (12)
|